Progyny, Inc.

PGNY · Healthcare

$25.66

Capitalización: 1.97B USDRendimiento por dividendo: —
Advance¿Es buen momento para comprar Progyny, Inc.? Pregunta a Copenvest AIObtén una lectura Advance con IA sobre timing, riesgo y qué hacen los inversores rastreados.Preguntar a Copenvest AI

Cargando gráfico…

Noticias

Últimos titulares de esta acción

GlobeNewswire Inc.7 ago 2026, 14:51

Progyny, Inc. to Present at the Canaccord Genuity Annual Growth Conference

Progyny, Inc. (Nasdaq: PGNY), a women's health and family building solutions company, announced that CEO Pete Anevski will present at the Canaccord Genuity 46th Annual Growth Conference in Boston on August 11, 2026. The company recently reported record quarterly revenue, gross profit, and adjusted EBITDA for Q2 2026, with strong demand continuing for its women's health and family building solutions.